Lipid Nanoparticles-Encapsulated YF4: A Potential Therapeutic Oral Peptide Delivery System for Hypertension Treatment

Drugs are administered orally in the clinical treatment of hypertension. Antihypertensive peptides have excellent angiotensin converting enzyme inhibitors activity in vitro. However, the poor oral bioavailability and therapeutic effect of antihypertensive peptides were mainly caused by rapid degrada...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shengnan, Li, Jinhua, Zhou, Yang, Huang, Lingjing, Li, Yanfei, Xu, Juanjuan, Fu, Chunmei, Guo, Xia, Yang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401629/
https://www.ncbi.nlm.nih.gov/pubmed/30873021
http://dx.doi.org/10.3389/fphar.2019.00102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401629/
https://www.ncbi.nlm.nih.gov/pubmed/30873021
http://dx.doi.org/10.3389/fphar.2019.00102

Ejemplares similares